Perron Institute
The Perron Institute is dedicated to neurological research, focusing on understanding and treating neurological conditions through innovative research, collaboration, and community engagement. It aims to translate scientific discoveries into therapies and improve the quality of life for people with neurological disorders.
Industries
Nr. of Employees
medium (51-250)
Perron Institute
Nedlands, Western Australia, Australia, Oceania
Products
Neuroprotective peptide candidate (preclinical)
A peptide therapeutic candidate demonstrated to reduce brain cell death in preclinical stroke models; compatibility with thrombolytic agents assessed and undergoing safety/toxicity verification prior to Phase I trials.
Ultra-high-throughput saliva molecular screening platform (pilot)
Saliva-based molecular testing workflow capable of processing large sample volumes rapidly for population-level viral surveillance with high reported accuracy in validation studies.
Neuroprotective peptide candidate (preclinical)
A peptide therapeutic candidate demonstrated to reduce brain cell death in preclinical stroke models; compatibility with thrombolytic agents assessed and undergoing safety/toxicity verification prior to Phase I trials.
Ultra-high-throughput saliva molecular screening platform (pilot)
Saliva-based molecular testing workflow capable of processing large sample volumes rapidly for population-level viral surveillance with high reported accuracy in validation studies.
Services
Multidisciplinary neurology clinics
Outpatient clinical services for stroke, multiple sclerosis, Parkinson’s disease, motor neurone disease and other complex neurological disorders combined with research activities.
Statewide telestroke consultation service
Remote stroke specialist consultations to support regional hospitals and provide rapid expert input for acute stroke management.
Centralised advanced imaging facility access
Access to a high-resolution multiphoton microscope and imaging infrastructure for deep tissue and cellular imaging available to researchers and industry via a booking system.
Clinical trial participant recruitment
Ongoing recruitment and coordination of participants for clinical studies in neurological disorders including stroke, MS and Parkinson’s disease.
High-throughput population screening validation
Pilot validation and ongoing evaluation of an ultra-high-throughput saliva molecular screening workflow for population surveillance of viral pathogens with rapid turnaround.
Multidisciplinary neurology clinics
Outpatient clinical services for stroke, multiple sclerosis, Parkinson’s disease, motor neurone disease and other complex neurological disorders combined with research activities.
Statewide telestroke consultation service
Remote stroke specialist consultations to support regional hospitals and provide rapid expert input for acute stroke management.
Centralised advanced imaging facility access
Access to a high-resolution multiphoton microscope and imaging infrastructure for deep tissue and cellular imaging available to researchers and industry via a booking system.
Clinical trial participant recruitment
Ongoing recruitment and coordination of participants for clinical studies in neurological disorders including stroke, MS and Parkinson’s disease.
High-throughput population screening validation
Pilot validation and ongoing evaluation of an ultra-high-throughput saliva molecular screening workflow for population surveillance of viral pathogens with rapid turnaround.
Expertise Areas
- Translational neuroscience
- Clinical trial recruitment and management
- Neurodegenerative disease research
- Brain stimulation and neuromodulation (rTMS)
Key Technologies
- Antisense oligonucleotides
- Repetitive transcranial magnetic stimulation (rTMS)
- Spatial transcriptomics
- Next-generation sequencing